Etanercept as Rescue Therapy for Refractory Kawasaki Disease
Journal: Austin Pediatrics (Vol.1, No. 2)Publication Date: 2014-05-27
Authors : Sandi C Lin; Wan-Lin Tseng; Mindy Ming-Huey Guo; Ho-Chang Kuo;
Page : 1-3
Keywords : Kawasaki disease; Etanercept; IVIG;
Abstract
Kawasaki disease is a febrile vasculitis occurring in infants and children treated with first line intravenous immunoglobulin (IVIG) and aspirin. However unresponsiveness to IVIG is not rare. This case report illustrates a girl with Kawasaki disease with fever persisting through two doses of IVIG and methylprednisolone and her fever was subsided only after using etanercept, a tumor necrosis factor-α antagonist.
Other Latest Articles
- Use of Adalimumab in a Patient with Juvenile Idiopathic Arthritis Refractory to Etanercept: a Case Report and Literature Review
- Using Brochures as Educational Tools to Promote Routine HIV Testing in Youth
- Nevus Sebaceous
- A Case of Neonatal Diabetes Presentation, Diagnosis and Management
- Calcifying Aponeurotic Fibroma of the Chest Wall in a 5-Month-Old Infant: A Case Report and Review of the Literature
Last modified: 2017-09-01 18:22:41